2012 Annual Meeting in Tampa, FL, April 29-May 2
Leadership Lessons Learned
All pharmacy practitioners are leaders in that we are all change agents and influencers of the thinking of our patients, students, and colleagues. Dr. Wells’ presentation is designed to help you select strategies to maximize your ability to bring about change in your professional setting and realize your potential to build programs, improve the care of patients, and increase your personal effectiveness.
2007 Annual Meeting Schedule
Sunday, April 15, 2007
8:00 - 11:00 am
Pre-meeting Workshop
Neuropsychological Assessment: Testing, Functional Implications and Enhancements
(Additional registration and fees required for participation)
Philip D. Harvey, PhD
11:15 am - 1:15 pm
Industry Symposium 1
Solvay/Wyeth
Compliance & Outcomes in the Management of Schizophrenia: Current Issues, New Options
Evidence-Based Practice Programming
1:30 - 2:45 pm
Maintenance Treatment of Bipolar Disorder+
Steve Stoner, PharmD, BCPP
2:45 - 3:45 pm
Eating Disorders:
Pharmacological Treatment of Eating Disorders+
Jim Roerig, PharmD, BCPP
4:00 - 5:00 pm
Obsessive-Compulsive Disorder+
Sara Augustin, PharmD, BCPP
5:00 - 6:00 pm
Treatment-Resistant Schizophrenia+
Debbie Thompson, PharmD, BCPP
Monday, April 16, 2007
8:00 - 8:30 am
Welcoming Remarks*
2006-2007 President, Matthew Fuller, PharmD, BCPS, BCPP, FASHP 2006-2007 Program Chair, Michael Wincor, PharmD, BCPP
8:30 - 9:30 am
Keynote Address: Six Decades of Psychopharmacology & Psychiatry: Advances a Challenge
Ross Baldessarini, MD
9:40 - 10:40 am
Neurobiology of Neuropsychiatric Disorders: The Role of Nutrition, Exercise, Sleep, Substance Use and Hormones
Martha P. Fankhauser, MS Pharm, FASHP, BCPP
11:00 am - 1:00 pm
Industry Symposium 2
BMS/Otsuka
An Evidence-Based Approach to the Management of Psychotic Disorders: The Role of the Pharmacist
Concurrent Programming
1:15 - 3:45 pm
Award Finalist Platform Presentations*
Core Programming on Traumatic Brain Injury
1:30 - 2:30 pm
Traumatic Brain Injury:
Cholinergic Hypothesis of Post Traumatic Cognitive Impairment
David Arciniegas, MD
2:50 - 3:50 pm
Traumatic Brain Injury:
The Catecholaminergic Hypothesis of Cognitive Impairment Following Traumatic Brain Injury
Thomas McAllister, MD
4:00 - 6:00 pm
Industry Symposium 3
Janssen, L.P.
Maximizing Benefit Using New Treatment Approaches for Patients with Schizophrenia
6:00 - 7:30 pm
Exhibitor and President’s Reception*
Tuesday, April 17, 2007
7:00 - 9:00 am
Industry Symposium 4
Lilly
Effectiveness as a Driver of Change: Impact of Antipsychotic Trials on Policy & Practice
9:00 am - 5:10 pm
Poster Displays (manned from 4:10-5:10)*
Concurrent Programming
9:10 - 10:10 am
Breakout 1:
Assessment of Sleep Disorders and New Treatments of Sleep Disorders and New Treatments of Excessive Daytime Sleepiness, Narcolepsy and Restless Legs Syndrome+
Cynthia K Kirkwood, PharmD, BCPP
Breakout 2:
Forensic Psychiatry Basics-Treatment of the Seriously Mentally Ill (SMI) in the Criminal Justice System
Mark Diamond, DO
10:20 - 11:20 am
Breakout 3:
Non-Pharmacologic Treatment of Sleep Disorders+
Clete A. Kushida, MD, PhD, RPSGT
Breakout 4:
Ten Years of Change in Providing Psychiatric Pharmacy Services in a Forensic Setting
Fred Raleigh, PharmD, BCPP
11:30 am - 12:30 pm
Breakout 5:
Pharmacologic Treatment of Insomnia+
Michael Wincor, PharmD, BCPP
Breakout 6:
Preparing to be a Forensic Expert: Lessons to be learned from Forensic Psychiatry
Jeffrey Metzner, MD
12:40 - 2:40 pm
Industry Symposium #5
Cephalon
Understanding Sleep/Wake Circuitry in the Context of Mood & Anxiety Disorders
3:00 - 4:00 pm
Breakout 7:
Practice Roundtable Discussions*
TBA
Breakout 8:
CPNP/ASCP-Aging with a Developmental Disability-Part I
Sara Dugan, PharmD, BCPP
William Rosenfeld, MD
4:10 - 5:10 pm
Breakout 9:
CPNP/ASCP-Aging with a Developmental Disability-Part II
Posters Manned*
Sara Dugan, PharmD, BCPP
William Rosenfeld, MD
6:30 - 9:30 pm
CPNP 10th Anniversary Celebration*
Wednesday, April 18, 2007
8:30 - 10:15 am
Town Hall Breakfast and Meeting*
10:30 - 11:30 am
Metabolic Disorders: Managing the Metabolic Syndrome in Patients with Psychiatric Disorders
Stuart Haines, PharmD, BCPS, BC-ADM
11:30 am - 12:30 pm
A Futuristic View of the Treatment of Alzheimer's Disease and Schizophrenia: Lessons from Early Drug Development
Larry Ereshefsky, PharmD, BCPP, FASHP
* Not Approved for ACPE Credit
+ Approved for BCPP Recertification Credit